CHINA M.SYS.H.CONS.DL-005 (2M7C.F) Financials
2M7C.F Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 18.4 billion | 2.4 billion |
2023-03-31 | ? | ? |
2022-12-31 | 17.8 billion | 3.0 billion |
2022-09-30 | ? | ? |
2M7C.F Free Cash Flow and Stock based compensation
No data available :(
2M7C.F Net Income
Date | Net Income |
---|---|
2023-06-30 | 960.5 million |
2023-03-31 | 960.5 million |
2022-12-31 | 730.1 million |
2022-09-30 | 730.1 million |
2M7C.F Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | - | - | 41.0 million |
2023-03-31 | - | - | - |
2022-12-31 | - | - | 29.3 million |
2022-09-30 | - | - | - |
2M7C.F Shares Outstanding
2M7C.F Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 4.8 million | - | - | - |
2023-03-31 | 4.8 million | - | - | - |
2022-12-31 | 4.7 million | - | - | - |
2022-09-30 | 4.7 million | - | - | - |
2M7C.F Cost of Revenue
No data available :(
2M7C.F
Price: €0.78
Dividend Yield: 0.47%
Forward Dividend Yield: 10.44%
Dividend Per Share: 0.08 EUR
Earnings Per Share: 0.13 EUR
P/E Ratio: 9.39
Exchange: FRA
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1936
Market Capitalization: 2.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 12
DGR3: 5.19%
DGR5: 3.62%
DGR10: 6.93%